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Pluripotent Stem Cells
Human Induced Pluripotent Cell-Derived
Sensory Neurons for Fate Commitment of
Bone Marrow-Derived Schwann Cells:
Implications for Remyelination Therapy
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ABSTRACT
Strategies that exploit induced pluripotent stem cells (iPSCs) to derive neurons have relied on cocktails
of cytokines and growth factors to bias cell-signaling events in the course of fate choice. These are often
costly and inefficient, involving multiple steps. In this study, we took an alternative approach and se-
lected 5 small-molecule inhibitors of key signaling pathways in an 8-day program to induce differenti-
ationof human iPSCs into sensoryneurons, reaching‡80%yield in termsofmarkerproteins. Continuing
culture in maintenance medium resulted in neuronal networks immunopositive for synaptic vesicle
markers and vesicular glutamate transporters suggestive of excitatory neurotransmission. Subpopula-
tions of the derived neurons were electrically excitable, showing tetrodotoxin-sensitive action poten-
tials in patch-clamp experiments. Coculture of the derived neurons with rat Schwann cells under
myelinating conditions resulted in upregulated levels of neuronal neuregulin 1 type III in conjunction
with the phosphorylated receptors ErbB2 and ErbB3, consistent with amenability of the neuritic net-
work to myelination. As surrogates of embryonic dorsal root ganglia neurons, the derived sensory neu-
rons provided contact-dependent cues to commit bone marrow-derived Schwann cell-like cells to the
Schwann cell fate. Our rapid and efficient induction protocol promises not only controlled differentia-
tion of human iPSCs into sensoryneurons, but alsoutility in the translation to aprotocolwherebyhuman
bonemarrow-derivedSchwanncellsbecomeavailable forautologous transplantationandremyelination
therapy. STEM CELLS TRANSLATIONAL MEDICINE 2016;5:1–13
SIGNIFICANCE
A highly efficient chemical protocol was developed to differentiate human induced pluripotent stem
cells (iPSCs) into functional sensory neurons. The derived sensory neurons expressed membrane-
bound cues that directed bone marrow-derived Schwann cell-like cells to fate-committed Schwann
cells with translational prospects in autologous transplantation and remyelination therapy. The iPSC-
derived sensory neurons may also prove useful in studies of sensory neuron biology, disease mod-
eling, and drug screening.
INTRODUCTION
Schwann cells transplanted into the injured envi-
ronments of peripheral nerve [1] and spinal cord
[2] switch on an axon-supportive program that
improves nerve regeneration and functional re-
covery [3, 4]. To take advantage of this unique
plasticity of Schwann cells in autologous trans-
plantation for therapy, sufficient numbers of
such cells are required, ideally without having
to sacrifice a peripheral nerve for the graft. Pre-
liminary works with cells from rodents have in
part addressed this need by in vitro derivation
of Schwann cell-like cells (SCLCs) frombonemar-
row stromal cells (BMSCs) [5–8]. The SCLCs were
then directed to fate commitment via contact-
mediated signaling in coculture with neurons
purified from dorsal root ganglia (DRG) of rat
embryos [8]. Subcultures of the derived Schwann
cells [9] demonstrated robust capacity for remye-
lination both in vitro [8] and in vivo [10]. The lim-
iting source of human DRG neurons, however,
presents a barrier to translation.
Until recently, strategies to derive function-
ally responsive human sensory neurons in suffi-
cient numbers from human pluripotent stem
cells have relied on complex, multistep proce-
dures [11–16] in recapitulation of events in the
early developing neuroepithelium or neural crest
cells. The advent of direct reprogramming of
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human fibroblasts via transcription factor overexpression her-
alds prospects of rapid and selective procedures to yield function-
ally defined classes of induced neurons [17–23]. The availability
of human induced pluripotent stem cells (iPSCs) and the possible
use of small molecules to induce cell lineage reprogramming [24]
offer the option of achieving differentiation of the iPSCs into sen-
sory neurons. In this study, we have adapted a selection of small-
molecule inhibitors (SMIs) of key signaling pathways [25, 26] for
the derivation of sensory neurons from a human iPSC line in an
8-day program, yielding sensory neurons at $ 80% efficiency
and bypassing the neural progenitor stage. The derived neurons
expressed key juxtacrine signals that specify the Schwann cell fate
and demonstrated amenability to myelination by Schwann cells,
thus fulfilling the need for a surrogate of human DRG neurons in
the translation to a protocol whereby human bone marrow-
derived Schwann cells achieve fate commitment andmeet safety
requirements for autologous transplantation and remyelination
therapy.
MATERIALS AND METHODS
Culture of Human iPSCs
Human iPS(IMR90) clone (no. 1) cells (WiCell Research Institute),
a gift from Dr. Elly S.W. Ngan (Department of Surgery, University
of Hong Kong), were maintained in culture on six-well plates
coated with human embryonic stem cell (hESC)-qualified matrix
(Stemcell Technologies, Vancouver, BC, Canada, http://www.
stemcell.com) in mTeSR1 (Stemcell Technologies). The medium
was changed every day. Cells were passaged using 1 mg/ml dis-
pase (Stemcell Technologies) in Dulbecco’s modified Eagle’s
medium (DMEM)/F-12, washed, and replated at dilutions of
1:4 to 1:8 (supplemental online Fig. 1). Cells were monitored
immunocytochemically for the ESC markers, OCT4, NANOG,
SSEA3, and SSEA4.
Generation of Sensory Neurons
Human iPSC colonies at 60% confluence were dissociated using
dispase and pelleted at 800 rpm for 4 minutes (room tempera-
ture). To generate sensory neurons, the cells were maintained
on Matrigel-coated plates in DMEM/F12 with defined supple-
ments plated at a density of 13 105 via one of three protocols.
(1) Three-step protocol: cultures were supplemented from day
1 with 10% KnockOut Serum Replacement (KSR) (Thermo
Fisher Scientific Life Sciences, Waltham, MA, http://www.
thermofisher.com), 1% penicillin/streptomycin (Thermo Fisher),
and 0.3 mM LDN-193189 (Cellagen Technology, San Diego, CA,
http://www.cellagentech.com) to day 5 and with 2 mM A83-01
(Cellagen Technology) to day 10; from day 5, with 6 mM
CHIR99021 (BioVision, Milpitas, CA, http://www.biovision.com)
to day 14; and from day 8, with 2mMRO4929097 (Cellagen Tech-
nology) and 3mMSU5402 (Tocris, Bristol, UK, http://www.tocris.
com) to day 14. (2) Two-step protocol: cultures were supple-
mented from day 1 with 10% KSR, 1% penicillin/streptomycin,
0.3 mM LDN-193189, and 2 mM A83-01 to day 7 and with
6 mM CHIR99021 to day 12; and from day 5, with 2 mM
RO4929097 and 3 mM SU5402 to day 12. (3) One-step proto-
col: cultures were supplemented from day 1 with 10% KSR, 1%
penicillin/streptomycin, 0.3 mM LDN-193189, 2 mM A83-01,
6 mM CHIR99021, 2 mM RO4929097, and 3 mM SU5402 to
day 8. Retinoic acid (0.3 mM; Sigma-Aldrich, St Louis, MO,
http://www.sigmaaldrich.com) was included in all cultures.
The medium was refreshed every 2 to 3 days. The neural induc-
tion protocols are outlined in supplemental online Figures 2 and
3 and Figure 1. To test cultures for stability of phenotype, cul-
tures were maintained in neurobasal medium supplemented
with 10 ng/ml neurotrophin 3, 20 ng/ml brain-derived neurotro-
phic factor, 20 ng/ml nerve growth factor (NGF), and 20 ng/ml
glial cell line-derived growth factor, with medium refreshed
every other day for up to 2 weeks. Cultures were then tested
for marker expression.
Immunofluorescence
For immunostaining, cells were rinsed once with phosphate-
bufferedsaline (PBS), fixedwith4%paraformaldehyde,andtreated
with blocking buffer (1% bovine serum albumin in PBS and 0.1%
Triton X-100). Cells were then incubated overnight at 4°C with
the selected primary antibodies: OCT3/4 (mouse monoclonal,
1:200; BD Biosciences, San Jose, CA, http://www.bdbiosciences.
com), NANOG (mouse monoclonal, 1:200; eBioscience, San Diego,
CA, http://www.ebioscience.com), SSEA3 (rat monoclonal, 1:100;
BD Biosciences), SSEA4 (mouse monoclonal, 1:100; BD Biosci-
ences), nestin (mouse monoclonal, 1:400; Abcam, Cambridge,
MA, http://www.abcam.com), PAX6 (mouse monoclonal, 1:200;
Santa Cruz Biotechnology, Santa Cruz, CA, http://www.scbt.
com), SOX2 (rabbit monoclonal, 1:200; Abcam), p75NTR (rabbit
polyclonal, 1:500; Abcam), HNK1 (mouse monoclonal, 1:200;
Sigma-Aldrich), AP2 (mouse monoclonal, 1:400; Sigma-Aldrich),
TUJ1 (mouse/rabbit monoclonal, 1:500; Covance Laboratories,
Dedham, MA, http://www.covance.com), neurofilament 200
(mouse monoclonal, 1:500; Covance Laboratories; rabbit
monoclonal, 1:100; Cell Signaling Technology, Danvers, MA,
http://www.cellsignal.com), peripherin (mouse monoclonal/
rabbit polyclonal, 1:500; Abcam), BRN3A (mouse monoclonal,
SantaCruz Biotechnology 1:200; Santa CruzBiotechnology; rabbit
monoclonal, 1:200; Abcam), NeuN (mouse monoclonal, 1:500;
EMD Millipore, Billerica, MA, http://www.emdmillipore.com),
Islet1 (mouse monoclonal/rabbit polyclonal, 1:400; Abcam), MAP2
(rabbit polyclonal, 1:200; Abcam), vesicular glutamate transporter
1 (VGLUT1) (rabbit polyclonal, 1:100;Abcam),VGLUT2 (rabbit poly-
clonal, 1:400; Novus Biologicals, Littleton, CO, http://www.
novusbio.com), VGLUT3 (rabbit polyclonal, 1:400; Alomone Labs,
Jerusalem, Israel, http://www.alomone.com), synapsin (rabbit
polyclonal, 1:500; EMD Millipore), VAMP/synaptobrevin (mouse
monoclonal, 1:400; Thermo Fisher Scientific Life Sciences), myelin
protein zero (P0; rabbit polyclonal, 1:200; Abcam), myelin basic
protein (MBP; mousemonoclonal, 1:500; EMDMillipore), galacto-
cerebroside (GALC; mouse monoclonal, 1:200; EMD Millipore),
ErbB2 (rabbit polyclonal, 1:400; Santa Cruz Biotechnology), ErbB3
(rabbit polyclonal, 1:400; Santa Cruz Biotechnology), CD90 (mouse
monoclonal, 1:200; BD Biosciences), CD73 (mouse monoclonal,
1:500; BD Biosciences), GFAP (mouse monoclonal, 1:100; Abcam),
and S100 (rabbit polyclonal, 1:200; Abcam). Cells were then incu-
bated with the appropriate secondary antibody for 2 hours
at 24°C. The secondary antibodies included Alexa Fluor 488-
conjugated goat antimouse immunoglobulin G (IgG) (1:300),
Alexa Fluor 594-conjugated goat antirabbit IgG (1:300), Alexa
Fluor 568-conjugated goat antimouse IgG (1:400), and Alexa
Fluor 555-conjugated goat antirabbit IgG (1:500) (all Thermo
Fisher). Nuclei were counterstained with 4,6-diamidino-2-
phenylindole (Abcam). Cells were viewed under an inverted
fluorescence microscope (Olympus IX7).
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Flow Cytometric Analysis
Cultures were dissociated with dispase, washed in PBS, and
blockedwith 2%bovine serumalbumin in PBS for 1 hour. The cells
were fixed and then incubated at 4°C for 30 minutes with appro-
priate primary antibodies at 1:50 dilution. Primary antibodies
were omitted in the negative controls. Double staining was per-
formed using fluorescein isothiocyanate-conjugated BRN3A
monoclonal antibody and phycoerythrin-conjugated peripherin
monoclonal antibody (Santa Cruz Biotechnology). Flow cytomet-
ric analysis was performed with use of BD CantoII Analyzer and
CellQuest software and set to record 20,000 events per sample.
For cell-cycle distribution analysis, the cells were harvested and
washed with PBS and fixed with 70% ethanol for 24 hours at
220°C. After washing, fixed cells were stained for at least
30 minutes in the dark with 25 mg/ml propidium iodide solu-
tion containing 200 mg/ml RNase A.
Western Blot Analysis
Whole cell lysates were prepared as previously described [27].
Briefly, cells in culture were washed with PBS and lysed with
Laemmli sample buffer containing protease and phosphatase in-
hibitors. Protein concentrations in sample lysates were deter-
mined by Bradford assay for equal protein loading per lane in
sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Pro-
tein patterns were electroblotted onto polyvinylidene difluoride
membrane (EMD Millipore). Nonspecific binding was blocked
with 5% nonfat skim milk at 24°C for 2 hours, and the epitope
of interest was probed overnight at 4°C. Primary antibodies used
Figure 1. One-step protocol for the differentiation of hiPSCs to sensory neurons. (A): Schematic outline of the protocol. (B): Morphological
changes in the progression from hiPSCs to sensory neurons as viewed under phase-contrast microscopy. Scale bars = 50 mm. (C): Neuronal
lineage marker expression by day-8 cells as detected by double immunofluorescence for TUJ1 and BRN3A (Ca), peripherin and neurofilament
(Cb), Islet1 and BRN3A (Cc), and Islet1 and peripherin (Cd). Scale bars = 50mm. Abbreviations: hiPSC, human induced pluripotent stem cell; SN,
sensory neuron.
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included those against neuronal neuregulin 1 (NRG1) type III
(rabbit polyclonal, 1:500), ErbB2 and phospho-ErbB2 (rabbit
polyclonal, 1:500), and ErbB3 and phospho-ErbB3 (rabbit poly-
clonal, 1:500) (all Santa Cruz Biotechnology). Additionally, blots
were probed for b-actin (rabbit polyclonal against b-actin,
1:500; Abcam) as internal reference. Secondary antibodieswere
conjugated with horseradish peroxidase. The membranes were
washed in Tris-buffered saline with Tween 20 between incuba-
tions. Visualization was enhancedwith an enhanced chemilumi-
nescence kit (EMD Millipore). Images were captured with the
ChemiImager 5500 imaging system (Alpha Innotech Co., San
Leandro, CA; http://www.alphainnotech.com).
Reverse-Transcription Polymerase Chain Reaction
Total RNA was extracted using TRIzol reagent according to the
manufacturer’s instructions, followed by DNase treatment
(ThermoFisher). RNA (2mg)wasused for first-strand complemen-
tary DNA (cDNA) synthesis. Reverse-transcription polymerase
chain reaction (RT-PCR) was performed with 200 ng cDNA, Taq
DNA polymerase, and the primers listed in supplemental
online Table 1. mRNA signals were quantified by densitomet-
ric analysis using a Biometra BioDoc-Analyzer, and the ratio of
their expression to that of a housekeeping gene (GAPDH) was
calculated.
Electrophysiology
The procedures for whole-cell patch-clamp recordings of human
iPSC-derived sensory neurons were performed at room temper-
ature (20–22°C) using methods described previously [28]. Low-
resistance recording pipettes (2–3 MV) were pulled from glass
capillaries. Neurons were visually identifiable by round-to-oval
soma. Extracellular solution contained 137 mM NaCl, 5 mM
KCl, 2 mM CaCl2, 1 mM MgCl2, and 10 mM glucose in 10 mM
HEPES, pH 7.4. The intracellular (pipette) solution contained
115 mM K-gluconate, 7 mM KCl, 0.05 mM EGTA, 2 mM Na2ATP,
2 mMMgATP, and 0.5 mM Na2GTP in 10 mM HEPES, pH 7.3. The
osmolarity of all solutions was maintained at 290 mOsm/l for the
extracellular solution and 300 mOsm/l for the intracellular solu-
tion. All chemicals were purchased from Sigma-Aldrich. To isolate
potassium currents, NaCl in the solution was replaced with
N-methyl-glucamine chloride Ringer. Currents were digitized at
25 kHz and filtered at 10 kHz. Action potentials were recorded
by holding the membrane potential at260 mV and injecting in-
creasing currents to elicit actionpotentials. Signalswere recorded
using an Axon MultiClamp 700B amplifier controlled by Clampex
10.2 software (Molecular Devices, Sunnyvale, CA, http://www.
molecular devices.com).
Human iPSC-Derived Sensory Neuron/Rat Schwann
Cell Cocultures
Cocultures of iPSC-derived sensory neurons and purified rat
Schwanncells fromneonatal rat sciatic nerves (ScienCell Research
Laboratories, Carlsbad, CA, http://wwwsciencellonline.com) were
prepared as described previously [8]. Neurite networks of iPSC-
derived sensory neurons were seeded with purified rat Schwann
cells at a density of 100,000 cells/coverslip in maintenance me-
dium containing 10 ng/ml NGF, 5 ng/ml neurotrophin 3, 10 ng/ml
brain-derived neurotrophic factor, 10 ng/ml glial cell line-derived
growth factor, 0.08% glucose, and 10% fetal bovine serum (FBS).
Medium was refreshed every 2 to 3 days. Five to 7 days later, the
coculture system was supplemented with 50 mg/ml ascorbic acid
(Sigma-Aldrich), 10 ng/ml NGF, 0.08% glucose, and 10% FBS to
inducemyelination by Schwann cells. Themediumwas refreshed
every 2 to 3 days for up to 2 weeks. Myelination was assessed in
terms of P0-, MBP-, and GALC-positive neurite segments observ-
able under fluorescence microscopy.
Generation of SCLCs and Coculture of SCLCs With
iPSC-Derived Sensory Neurons
Our previous study demonstrated that contact-mediated signal-
ing provided by embryonic DRG neurons is essential for the SCLCs
to become fate-committed Schwann cells [8]. Here we asked
whether the iPSC-derived sensory neurons can serve as an alter-
native to the limiting source of DRG neurons. SCLCs were derived
from rat BMSCs as described [8]. SCLCs were seeded onto the
iPSC-derived sensory neurons at 3,000 cells/cm and maintained
for 2 weeks in coculture medium: glutamine-free a-minimum
essential medium and neurobasal medium (1:1, vol/vol) supple-
mented with 2.5 mM forskolin, 2.5 ng/ml platelet-derived growth
factor,5ng/mlbasic fibroblastgrowthfactor,100ng/mlb-heregulin,
5 ng/ml NGF, 1% (vol/vol) B27, and 5% FBS. Every 2 to 3 days, 50%
of the medium was replaced with fresh medium. After passaging
to remove iPSC-derived sensory neurons, the surviving cells were
maintained in basal medium (DMEM/F12 with 10% FBS) for at
least 1 week. Cells that stained positive for Schwann cell markers
at this post-coculture stage were termed committed Schwann
cells. SCLC cultures that had not been cocultured with iPSC-
derived sensory neurons were maintained in parallel under the
same conditions as controls.
Statistical Analysis
Statistical analyses were performed using a commercially
available software package (Prism 5; GraphPad, San Diego,
CA, http://www.graphpad.com). Data are presented as
mean 6 SEM or SD as indicated. Statistical significance
was assessed using Student’s t test or nonparametric analy-
sis of variance. All experiments were repeated at least five
times.
RESULTS
Derivation of Sensory Neurons From Human iPSCs
To begin with, the human iPSC colonies homogeneously showed
immunoreactivities for ESC markers, OCT4, NANOG, SSEA3, and
SSEA4 (supplemental online Fig. 1). In the 3-step protocol
(supplemental online Fig. 2), day-5 cells that had been sub-
jected to dual-Smad inhibition with LDN-193189 and A83-01
showed immunopositivity for the neural progenitor cell (NPC)
markers, PAX6, nestin, and SOX2. Next, via supplementation
with CHIR99021 to inhibit glycogen synthase kinase-3b and
thus maintain Wnt/b-catenin signaling, day-8 cells showed pro-
nounced immunopositivity for the neural crest stem cell (NCSC)
markers, p75NTR, HNK1, and AP2. Finally, via supplementation
with RO4929097 (a g-secretase inhibitor of Notch signaling)
and SU5402 (an inhibitor of FGFR1-specific tyrosine kinase) in
the context of CHIR99021, day-14 cells showed immunopositiv-
ity for themarkers TUJ1, neurofilament, BRN3A, and Islet1, sug-
gestive of sensory neurogenesis.
In the 2-step protocol (supplemental online Fig. 3), day-5 cells
that had been treated in concert with LDN-193189, A83-01, and
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CHIR99021 showed pronounced immunopositivity for the NCSC
markers, p75NTR, HNK1, and AP2. Then, under CHIR99021,
RO4929097, and SU5402, day-12 cells showed immunopositivity
for markers of the sensory neuron lineage.
In the1-step protocol, human iPSCs that hadbeen treated con-
currently with LDN-193189, A83-01, CHIR99021, RO4929097, and
SU5402 in an 8-day program (Fig. 1A) showed progressive changes
inmorphology, from round or fusiform cells with dense and prom-
inent nucleoli to ones with compact cell bodies and multiple
processes that in time apparently formed interconnecting net-
works (Fig. 1B).
Immunocytochemical staining showed that most of the de-
rived cells were positive for markers of neuronal cytoskeleton,
TUJ1, and neurofilament (supplemental online Fig. 4A) and neu-
ronal nuclear antigen, NeuN (supplemental online Fig. 4B). Dou-
ble immunofluorescence showed coexpression of these markers
with thoseof the sensoryneuron lineage, suchas TUJ1andBRN3A
(Fig. 1Ca), peripherin and neurofilament (Fig. 1Cb), Islet and
BRN3A (Fig. 1Cc), and Islet and peripherin (Fig. 1Cd). These
iPSC-derived neurons were confirmed to be immunonegative
for the NPC markers, PAX6 and nestin (supplemental online Fig.
5A, 5B) as well as the neural crest cell markers, AP2, HNK1, and
p75NTR (supplemental online Fig. 5C–5E). Phenotypic stability
of the iPSC-derived neurons in neural maintenance medium in
the absence of SMIs could bemaintained for 2weeks as indicated
by immunopositivity for TUJ1 and neurofilament (Fig. 2Aa),
peripherin and Islet1 (Fig. 2Ab), or BRN3A (Fig. 2Ac). Flow cyto-
metric analysis of the iPSC-derived neurons for TUJ1, neurofila-
ment, Islet, and NeuN showed percentages as high as 91.41%,
92.39%, 80.17%, and 74.65%, respectively, compared with the
negative control; in contrast, immunopositivity for PAX6, nestin,
AP2, and HNK1 was negligible, being less than 1% (Fig. 2B). A rep-
resentative dot plot of peripherin-positive counts (y-axis) against
BRN3A-positive counts (x-axis) showed that 78% of the popula-
tion (F2, Fig. 2C) was doubly positive for the sensory neuron
markers.
We then sought confirmation via RT-PCR analysis for expres-
sion at the mRNA level. The set of sensory neuron markers not
only was expressed among cells exposed to SMIs, but was also
as highly expressed among cells in maintenance medium after
withdrawal of SMIs (Fig. 3Aa). Semiquantitative analysis revealed
$ 16-fold induction of BRN3Aand $ 20-fold induction of periph-
erin expression in the derived neurons compared with the paren-
tal iPSCs (Fig. 3Ab). Furthermore, fluorescence-activated cell
sorting analysis found a decrease in the proportion of cells in
the cell cycle (Fig. 3Ba, 3Bb), in support of the increase in propor-
tion of cells directed to the sensory neuron lineage after treat-
ment with the SMIs. Numerous TUJ1-positive cells coexpressed
MAP2 (Fig. 4Aa), a neuron-specific marker protein that stabilizes
microtubules in dendrites of mature neurons. Immunopositivity
for VGLUT1 (Fig. 4Ab), VGLUT2 (Fig. 4Ac), and VGLUT3 (Fig.
4Ad) suggests that the neurons were in preparation for glutama-
tergic transmission, as supported by the finding of TUJ1-positive
cells showing immunopositivity for the synaptic vesicle proteins,
synapsin (Fig. 4Ba) and VAMP (Fig. 4Bb).
Electrophysiological Properties of iPSC-Derived
Sensory Neurons
Whole-cell patch-clamp recordings were selectively performed
on derived neurons displaying bipolar morphology (Fig. 5A). In
total,we recorded28 cells, ofwhich 25 (89.3%) fired action poten-
tials in response to depolarizing current pulses (Fig. 5Ba). The ma-
jority of cells (53.6%, n = 15) fired a single spike in response
to depolarization (Fig. 5Bb). As demonstrated in Figure 5Bc,
multiple spikes could be generated in a subpopulation of the de-
rived neurons (35.7%, n = 10) after suprathreshold current injec-
tions. These spikes were abolishedwith use of 1mMtetrodotoxin
(TTX) but were recoverable after washout, suggesting that TTX-
sensitive voltage-gated channels were in operation in the derived
neurons for the generation of action potentials. In response to in-
cremental voltage steps from 260 mV to +30 mV (10-mV incre-
ments), 82% of the sampled neurons (n = 23) displayed inward
fast-inactivating sodium and a large outward current with little
or no inaction, typical of a delayed, rectifying K+ current (Fig.
5Ca). The sustained portion of the outward current increased
steadily with increasing depolarization (Fig. 5Cb). These data
demonstrate that the iPSC-derived sensory neurons possess
membrane and electrophysiological properties that are charac-
teristic of functional neurons.
Human iPSC-Derived Sensory Neurons Engaged in
Contact-Mediated Signaling With Rat Schwann Cells
in Coculture
Myelination requires activation of NRG1 type III and ErbB signal-
ing at the Schwann cell-axon junction. We established the cocul-
ture model of iPSC-derived sensory neurons with purified rat
Schwann cells and determined the interaction of the two cell
types after the initiation of myelination. After 3 weeks in cocul-
ture, segments that were positive for myelin proteins P0 (Fig.
6Aa), MBP (Fig. 6Ab), and GALC (Fig. 6Ac) formed along axon
bundles of the derived sensory neurons. The increased level of
NRG1 type III in extracts of cocultures was confirmed byWestern
blot analysis (Fig. 6Ba, 6Bb). ErbB2- and ErbB3-positive cells
(supplemental online Fig. 6Aa, 6Ab) observable along the neuritic
networks of derived sensory neurons are likely Schwann cells.
The observation of phosphorylated proteins p-ErbB2 and p-ErbB3
in Western blots (supplemental online Fig. 6Ba, 6Bb) further
supports that NRG1 type III interaction with ErbB2-ErbB3 hetero-
dimer activated receptor cross-phosphorylation and downstream
signaling in the coculture.
Commitment of SCLCs to Schwann Cells After Coculture
With Human iPSC-Derived Sensory Neurons
SCLCswere derived from rat BMSCs as described [8] (supplemental
online Fig. 7). Seven days after coculture, SCLCs adopted typical
Schwann cell morphology and organization (Fig. 7A). One week
later, these cells increased in number, and a lot of cells formed a
network (Fig. 7A). After passaging and withdrawal of both glio-
genic cocktail and iPSC-derived sensory neurons, the Schwann
cell culture was negative for TUJ1 (Fig. 7Bb), confirming the ab-
sence of neurons. The culture of committed Schwann cells dem-
onstrated persistence of spindle-shaped morphology (Fig. 7Ba).
Immunopositivity for Schwann cell markers S100 and p75NTR
(Fig. 7Bc) was observable in 80.7% 6 5.3% and 83.2% 6 6.1%,
respectively, of the committed Schwann cells. In contrast, the
ratios of positively stained cells in parallel SCLC cultures were
as low as 10.1% 6 1.8% and 14.3% 6 2.1%, respectively (Fig.
7Bd). Taken together, these results show that the derived sen-
sory neurons conferred the contact-dependent cues necessary
for switching SCLCs to the Schwann cell fate.
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Figure 2. Continuing culture of human iPSC-derived neurons inmaintenancemedium for 14 days. (A):Neuronal lineagemarker expression by
the iPSC-derived neurons as detected by double immunofluorescence for TUJ1 and neurofilament (Aa), peripherin and Islet1 (Ab), and periph-
erin and BRN3A (Ac). Scale bars = 50 mm. (B): Representative dot plots of flow cytometric data showing the percentage of iPSC-derived cells
positive for TUJ1 (91.41%), neurofilament (92.39%), Islet1 (80.17%), and NeuN (74.65%) but not for PAX6, Nestin, AP2, and HNK1 (,1%). (C):
Representative dot plot of two-color flowcytometric data showing subpopulations of the iPSC-derived cells: F1, low inBRN3Abut high in periph-
erin; F2, high in both BRN3A and peripherin; F3, low in both BRN3A and peripherin; F4, high in BRN3A but low in peripherin. Abbreviations: FITC,
fluorescein isothiocyanate; iPSC, induced pluripotent stem cell; PE, phycoerythrin; SSC, side scatter.
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DISCUSSION
The phenotypic instability of bone marrow-derived SCLCs is at issue
with the intendeduseof thesecells fornerverepairandregeneration
after therapeutic transplantation. In this work, we demonstrate that
commitment to the Schwann cell fate can be acquired by SCLCs in
coculturewithsensoryneuronsviacontact-dependentcues,mimick-
ing the niche within developing DRGs. Although access to incipient
neurons of developing DRGs harvested from human embryos is lim-
iting,herewedemonstratetheuseofahumaniPSC linetobypass the
translational barrier. By various combinations of SMIs of cellular sig-
nalingpathways,wearrived at an8-dayprogramthat effectively and
efficiently fostered differentiation of a human iPSC line into sensory
neurons with respect to morphology, marker protein expression,
electrophysiological properties, and amenability to myelination by
Schwann cells.
To direct differentiation of iPSCs to sensory neurons, the fol-
lowing steps are critical: (a) exit from the pluripotent state, (b)
differentiation into the lineages of embryonic tissues rather
than extraembryonic tissues, (c) differentiation into ectoderm
rather than primitive streak, (d) differentiation into neural cells
rather than epidermal cells [29], and (e) differentiation into cells
of the neural crest lineage rather than those of the central ner-
vous system. Smad signals have multiple effects in each step of
differentiation. Because TGFb/Activin/nodal-mediated Smad sig-
naling maintains the pluripotency of human ESCs, inhibition of
this signal results in induction of differentiation [30]. BMP4-
mediated Smad signaling initiates differentiation into trophoblasts
[31] or extraembryonic tissue [32], whereas nodal has an inhibitory
effect on this step. Both BMP and Activin signals block ectodermal
differentiation and promote the development of primitive
streak [33]. After ectodermal differentiation, BMP4 blocks neural
Figure 3. Stability of human iPSC-derived sensory neurons in terms of marker expression and cell-cycle profile. (A): Semiquantitative reverse
transcription-polymerase chain reaction analysis revealed sustained expression of mRNA for TUJ1, Islet1, peripherin, and BRN3A in iPSC-iSNs
on day 8 of SMI treatment (+SMIs) and those on day 14 ofmaintenance treatment with neurobasal medium and growth factors (+GFs) as shownwith
ethidiumbromide-stainedgelpatterns (Aa)anddensitometric scansofthespecificmarkerrelativetothatofGAPDH (Ab).pp,p, .01;ppp,p, .005, iSNs
(+SMIs), iSN (+GFs) vs. iPSCs. (B): Cell-cycle analysis revealed that the proportion of cells in the G2/M phase remained as low as those in the G0/G1
phase for iSN (+SMIs) and iSN (+GFs). p, p, .05, iSNs (+SMIs), iSN (+GFs) vs. iPSCs. Abbreviations: GAPDH, glyceraldehyde-3-phosphate
dehydrogenase; GF, growth factor; iPSC, induced pluripotent stem cell; iSN, induced sensory neuron; SMI, small-molecule inhibitor.
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differentiation and promotes epidermal development. Inhibi-
tion of BMP signaling promotes neural differentiation [34].
Thus, concurrent inhibition of Smad signaling effected the dif-
ferentiation of ESCs and iPSCs into specific cell types of the
central nervous system [25, 35–37]. Canonical Wnt signaling,
which inhibits glycogen synthase kinase 3, performs roles in
promoting neural crest formation in vertebrate development
[38–40]. Elevating Wnt signaling in the context of low Smad
activity would divert early neuroectoderm away from an
NPC fate toward a neural crest-like identity [37]. Activation
of canonical Wnt signaling is also capable of instructing naive
neural crest precursors toward the sensory neuron lineage.
Notch signaling is also involved in maintaining cell pluripo-
tency. Blocking Notch signaling can mediate the loss of plu-
ripotency and drive neural differentiation of pluripotent
stem cells. Based on the functions of SMIs, we chose to inhibit
Smad with LDN193189, a potent inhibitor of BMP-mediated
Smad signaling [41], and A83-01, a selective inhibitor of
Activin-mediated Smad signaling, which is more potent than
the commonly used SB431542 [42]. RO4929097, a member
of the secretase inhibitor family, was included to enhance
neurogenesis by interfering with Notch signaling [36, 43].
Figure 4. Immunodetection of synaptic vesicle-associated proteins in human iPSC-derived neurons. (A): Double immunofluorescence
revealed MAP2 (Aa), VGLUT1 (Ab), VGLUT2 (Ac), and VGLUT3 (Ad) in TUJ1-positive iPSC-derived neurons on day 14 of maintenance treat-
ment. Scale bars = 50 mm. (B): Double immunofluorescence revealed synapsin (Ba) and VAMP (Bb) along neurites of iPSC-derived neurons.
Nuclei were visualized with DAPI. Scale bars = 50 mm. Abbreviations: DAPI, 49,6-diamidino-2-phenylindole; iPSC, induced pluripotent stem
cell; VGLUT, vesicular glutamate transporter.
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Figure 5. Electrophysiological properties of the human iPSC-derived sensory neurons. (A): Photomicrograph showing a patch pipette attached
to an iPSC-derived neuron. Scale bar = 10 mm. (B): Current-clamp recording of membrane potential in iPSC-derived neurons: proportion of
neurons showing null/single/multiple action potential firing as evoked with step-current injection (Ba); example recording of a single action
potential evoked by current injection of 50 pA for 1 second (Bb); and example recording of multiple action potential firing as evoked by current
injection of 80 pA for 1 second (Bc). Application of TTX blocked the generation of action potentials, but after washout, action potential firing
could again be evoked. (C): Voltage-clamp recording of specific ion currents: example recording of delayed rectifier K+ current evoked by depo-
larizing steps ranging from260mV to +30mV (Ca); and steady-state current-voltage relationship for the cell examined (Cb). Abbreviations: AP,
action potential; iPSC, induced pluripotent stem cell; iSN, induced sensory neuron; TTX, tetrodotoxin.
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CHIR99021, acting as a Wnt agonist by selectively inhibiting
glycogen synthase kinase 3b [26], was used in our protocol
to accelerate neural crest formation and specification of sen-
sory neurons [44, 45]. SU5402, a potent inhibitor of FGFR1 sig-
naling, was also applied not only to facilitate specification of
neuroectodermal fate via PAX6 induction among human iPSCs
but also to promote sensory neuron differentiation after neu-
roectoderm formation [46].
We then explored schedules of combinations of the SMIs for
thederivationof sensoryneurons fromhuman iPSCs. In the3-step
protocol, human iPSCs were induced to differentiate into PAX6-
positive NPCs via inhibition of both BMP and Activin A/nodal
signaling with LDN193189 and A83-01 for 5 days. Then, use of
CHIR99021 in the context of A83-01 effected the differentiation
of the early PAX6-positive population to p75NTR-positive neural
crest cell fates. Omission of LDN193189 had no major impact, in-
dicating that active suppression of BMP signaling is not re-
quired at this stage (data not shown), as had been reported
[37]. Subsequently, treatment with RO4929097 and SU5402
in the context of CHIR99021 directed differentiation into neu-
rons positive for markers of the sensory lineage. Because
NCSCs and NPCs are developmentally derived from ectoderm
progenitor cells, we reasoned that dual-Smad inhibition in
combination with Wnt activation would speed up the deriva-
tion of neural crest cells from iPSCs. Thus, treatment of iPSCs
with CHIR99021, A83-01, and LDN-193189 resulted in a highly
enriched p75NTR-positive neural crest-like population within
5 days. Subsequent exposure to CHIR99021, RO4929097,
and SU5402 facilitated the conversion to sensory neurons.
The 2-step protocol took 12 days, in contrast to 14 days re-
quired for the 3-step protocol.
Given that the starting population of iPSCs are likely hetero-
geneous in molecular states that are responsive to the differen-
tiation signals, we speculated that the cocktail of SMIs could
generate synergism in the differentiation program to sensory
neurons. We therefore attempted a one-step treatment of the
iPSCs with a cocktail of the five SMIs. Under 6–8 days of treat-
ment, the vast majority of cells progressively adopted neuronal
Figure 6. Contact-mediated signaling between human iPSC-derived sensory neurons and rat Schwann cells in coculture. (A): Images ofmyelin-
like segments along neuritic networks of human iPSC-derived sensory neurons in coculture with rat Schwann cells for 14 days in medium sup-
plementedwithascorbic acid.Double immunofluorescence forP0/neurofilament (Aa),MBP/neurofilament (Ab), andGALC/neurofilament (Ac).
Cell nuclei were visualizedwith DAPI. Scale bars = 50mm. (Ba):Western blot analysis for NRG1 type III in cell lysates prepared from iPSC-derived
iSNs alone or iSN-Schwann cell cocultures for the indicated days under nonmyelinating conditions. Schwann cells were given this period to
populate the neurites before induction ofmyelinationwith ascorbic acid supplementation. (Bb):Histogram showing NRG1 type III band density
as normalized against the corresponding actin band density. NRG1 type III was detectable in extracts of iSNs and at increased levels in extracts of
cocultures, leveling off by day 3 of coculture (Ba). p, p, .05, cocultures at days 1, 3, and 5 vs. iSNs alone. Abbreviations: DAPI, 49,6-diamidino-2-
phenylindole; GALC, galactocerebroside; iPSC, induced pluripotent stem cell; iSN, induced sensory neuron; MBP, myelin basic protein; NRG1,
neuregulin 1.
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morphology and expressed not only cytoskeletal proteinmarkers
of neurons but also the transcription factors, BRN3A, Islet, and
NeuN, identifiablewith sensory neurons. The resulting cellswere,
however, negative for NPC markers as well as neural crest cell
markers, suggesting swift synchrony in the conversion from plu-
ripotent stem cells to peripheral neurons. Follow-up cultures of
the derived sensory neurons in neural maintenance medium
found expression of the three vesicular glutamate trans-
porters 1, 2, and 3 (VGLUT1, VGLUT2, and VGLUT3) but
not GABA (data not shown). A number of TUJ1-positive cells
expressed the synaptic vesicle proteins, synapsin and VAMP,
suggesting the capacity of forming synapses in the neuronal
network and releasing glutamate in excitatory neurotrans-
mission. We have therefore sped up the time frame for gen-
erating the sensory neuron phenotype as an improvement
over published protocols [12, 47]. Whole-cell patch-clamp re-
cordings indicated that the induced neurons could evoke sin-
gle action potential-like spikes in response to a depolarizing
step current or multiple spikes with increasing intensity of
the step current. That these spikes could be blocked with bath
administration of TTX further suggests that the derived cells
had differentiated into functional and electrically active
neurons.
The level of NRG1 type III expressed on axons plays a key
role in graded activation of ErbB2/3 heterodimers on the
Schwann cell membrane and downstream signaling that culminate
in fate choice between axonal ensheathment and myelination by
Schwann cells [48–52]. This was reinforced by our finding, in co-
cultures of the derived neurons and rat Schwann cells, that the
nonmyelinating condition primed neurons with upregulated ex-
pression ofNRG1 type III, whereaswithin 2 days of the transition
to myelinating condition, contact-mediated signaling between
neuronal NRG1 type III and glial ErbB2/3 receptors was detect-
able as phosphorylated forms of ErbB2/3. Myelin-like segments
in alignment with neurites were evident in the myelinating co-
cultures. It remains unclear whether the neurite level of NRG1
type III determined Schwann cell ensheathment versusmyelina-
tion or that, given time, the Schwann cells would have estab-
lished mature myelin on the neurites. Admittedly, the status
of compact myelin formation needs verification by analysis of
electron micrographs.
Earlier efforts of in vitro derivation of SCLCs from rat BMSCs
used a cytokine/growth factor cocktail [8, 9]. However, the
SCLCs lacked fate commitment and reverted to a fibroblast-
like phenotype upon withdrawal of differentiation-inducing
factors [53], and the phenotypically unstable SCLCs demon-
strated limited capacity for remyelination. By coculture with
embryonic rat DRG neurons, rat SCLCs were directed to fate
commitment; consequently, the derived Schwann cells dem-
onstrated robust capacity for remyelination in vitro [8] and
in vivo functional recovery after transplantation as a Schwann
cell-seeded guidance channel bridging a critical gap in a rat
model of sciatic nerve injury [10]. More importantly, the
iPSC-derived sensory neurons generated in the present study
can be used to replace rat DRG neurons in providing neural
membrane effectors that switch the SCLCs to committed
Schwann cells.
In sum, knowledge of key signaling pathways is instrumen-
tal in establishing culture conditions for the differentiation of
human iPSCs along a neuroectoderm pathway for the genera-
tion of neuronal subtypes. Here we report that concurrent ac-
tivation of canonical Wnt signaling under conditions of low
global Smad signaling, as well as low Notch and FGFR1 signal-
ing, is adequate for inducing rapid differentiation of human
Figure 7. Commitment of SCLCs to Schwann cell fate after coculture
with iPSC-derived sensory neurons. (A): Phase-contrast images showing
SCLCs on days 7 and 14 of coculture with iPSC-derived sensory neurons.
Scale bar = 100 mm. (B): Fate-committed Schwann cells subcultured in
basal medium without supplementation of glia-inducing factors as
viewed under phase-contrastmicroscopy (Ba) and fluorescencemicros-
copy (Bb, Bc). No sign of TUJ1-positive neuronswas detectable (Bb), but
the fate-committed Schwann cells were positive for both S100 and
p75NTR (Bc). Histogramshowingpercentages ofDAPI-stained cells show-
ing immunopositivity for S100andp75NTR in culturesof SCLCs (openbar)
versusthoseof fate-committedSchwanncells (filledbar) (Bd). Scalebar=
100mm.pp,p, .01, committed Schwann cells vs. SCLCs. Abbreviations:
DAPI, 4, 6-diamidino-2-phenylindole; iPSC, induced pluripotent stem
cell; SCLC, Schwann cell-like cell.
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iPSCs into sensory neurons. This protocol is a major improve-
ment over publishedmethods in that the single-step induction
could conveniently be performed in chemically defined me-
dium using small-molecule compounds that are stable and
cost-effective. Populations of derived sensory neurons may then
be used in the translation to a protocol whereby human bone
marrow-derived Schwann cells achieve fate commitment and
meet safety requirements for autologous transplantation and
remyelination therapy.
CONCLUSION
Wedeveloped ahighly efficient chemical protocol todifferentiate
human iPSCs into functional sensory neurons. We found that the
derived sensory neurons expressed membrane-bound cues that
direct bone marrow-derived SCLCs to fate-committed Schwann
cells with translational prospects in autologous transplantation
and remyelination therapy. The iPSC-derived sensoryneuronswill
also be of utility in studies of sensory neuron biology, disease
modeling, and drug screening.
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